| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046496560 |
| P356 | DOI | 10.1007/S00213-004-2072-7 |
| P698 | PubMed publication ID | 15609068 |
| P2093 | author name string | Shigetoshi Kuroda | |
| Takashi Hamamura | |||
| Shinji Miyata | |||
| Hideki Taoka | |||
| Shiro Endo | |||
| Takuro Oka | |||
| Toshiaki Habara | |||
| Youmei Lee | |||
| Masahito Miki | |||
| P2860 | cites work | Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial | Q51685605 |
| Working memory dysfunction in major depression: an event-related potential study. | Q52024885 | ||
| Changes in directed attention and short-term memory in depression. | Q52167396 | ||
| Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels | Q70850535 | ||
| P-chloroamphetamine induces c-fos in rat brain: a study of serotonin2A/2C receptor function | Q71323717 | ||
| Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial | Q71389924 | ||
| The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome | Q72308095 | ||
| Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex | Q72334786 | ||
| A low dose of lithium chloride selectively induces Fos protein in the central nucleus of the amygdala of rat brain | Q73759278 | ||
| A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder | Q77339755 | ||
| Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder | Q77374064 | ||
| Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder | Q28137879 | ||
| Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs | Q28209414 | ||
| Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines | Q28215161 | ||
| The use of c-fos as a metabolic marker in neuronal pathway tracing | Q28244965 | ||
| Theories of basal forebrain organization and the "emotional motor system". | Q30469017 | ||
| From symptoms to social functioning: differential effects of antidepressant therapy | Q33723345 | ||
| The orbitofrontal cortex and reward | Q33871858 | ||
| Neuroimaging studies of mood disorders | Q33924331 | ||
| Sertraline-induced panic attacks | Q33969046 | ||
| Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin? | Q33972245 | ||
| The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep and cat. | Q34008940 | ||
| Reduced volume of orbitofrontal cortex in major depression | Q34124198 | ||
| Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals | Q34155656 | ||
| Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder | Q34158981 | ||
| Expression of c-fos protein in brain: metabolic mapping at the cellular level | Q34167261 | ||
| The cellular neurobiology of depression | Q34236134 | ||
| Integrating orbitofrontal cortex into prefrontal theory: common processing themes across species and subdivisions | Q34272410 | ||
| Pre-frontal executive committee for perception, working memory, attention, long-term memory, motor control, and thinking: a tutorial review | Q35078288 | ||
| SPECT and PET imaging in mood disorders | Q36758760 | ||
| Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis | Q41485902 | ||
| Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. | Q42146017 | ||
| An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice | Q43695347 | ||
| Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test | Q43891479 | ||
| Effect of 5-HT1A receptor-mediated serotonin augmentation on Fos immunoreactivity in rat brain | Q44225214 | ||
| Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients | Q44255099 | ||
| Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. | Q44278076 | ||
| Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs. | Q44588977 | ||
| c-Fos response to administration of catecholamines into brain by microdialysis | Q44954898 | ||
| The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system | Q48110278 | ||
| The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
| Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. | Q48394832 | ||
| Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens | Q48604619 | ||
| Do noradrenaline and serotonin differentially affect social motivation and behaviour? | Q48759711 | ||
| Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine | Q49030374 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluoxetine | Q422244 |
| P304 | page(s) | 289-295 | |
| P577 | publication date | 2004-11-17 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect | |
| P478 | volume | 177 |
| Q33683807 | Berberine produces antidepressant-like effects in ovariectomized mice |
| Q35622636 | Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin |
| Q35137628 | Effect of antidepressant drugs on the vmPFC-limbic circuitry |
| Q41819309 | High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor. |
| Q43542890 | Imipramine-induced c-Fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats |
| Q50879617 | Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. |
| Q44644323 | Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging. |
| Q82693769 | Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced fos expression in overlapping brain regions |
| Q33763617 | Pattern of c-Fos expression induced by tail suspension test in the mouse brain |
| Q42052984 | Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat. |
| Q36691772 | Regulators of G-protein-coupled receptor-G-protein coupling: antidepressants mechanism of action |
Search more.